biological design

A new report from the Genesis Mission examines how artificial intelligence is being applied to fusion energy research and biological design. The analysis covers AI's potential to accelerate scientific discovery in these fields, including modeling complex plasma behavior and engineering biological systems. The report is drawing attention from readers following the broader push to apply advanced computing and AI to national science and energy priorities.

Laboratory management professionals are highlighting the need for formal biosafety oversight when artificial intelligence systems direct wet-lab experiments. The concern is that AI-designed protocols could bypass traditional risk review, creating biological safety and security gaps. Discussion centres on updating institutional biosafety committees and lab protocols to cover AI-generated experiment designs before they are carried out in facilities.

Google DeepMind has announced SynthID Bio, a set of watermarking methods for synthetic biology. The tool is designed to embed identifiable markers into engineered biological sequences, so lab-designed DNA can be distinguished from natural genetic material. The announcement follows the earlier SynthID system used to watermark AI-generated text and images, and is being read as DeepMind extending its provenance technology into biotechnology and biosecurity.

Google has announced SynthID Bio, extending its SynthID watermarking technology to synthetic biology. The tool is designed to embed detectable markers into synthetic DNA, helping researchers verify whether biological sequences were made in a lab. The move signals Google's push to apply AI-origin identification beyond digital media into biotechnology safety.

Researchers have described a method for embedding watermarks into proteins designed by artificial intelligence while keeping the molecules' function intact. The approach, published in Nature, would allow lab-designed proteins to be identified as AI-generated without disrupting how they work. It is being discussed as a possible step toward transparency and traceability in synthetic biology and AI-assisted protein design.

Microsoft Research has introduced Quine, a multimodal world model of biology. According to a report by Unite.AI, the system is designed to integrate different types of biological data into a unified model. Details about its capabilities, benchmarks and intended applications remain limited in the initial coverage, and independent expert reaction has not yet been reported.

10x Genomics has started shipping its Atera spatial biology platform, marking a commercial rollout of the new instrument. The system is designed to let researchers map gene activity within intact tissue, an area of growing interest in drug development and disease research. The company says deliveries to customers are now underway, though details on launch customers and pricing have not been given.

Researchers have introduced GenAI-Net, a generative AI framework that automates the design of biomolecular networks. The framework uses generative models to construct network designs without manual intervention, potentially speeding up work in systems biology and bioengineering. Coverage so far is limited to the announcement, with details on validation and applications not yet widely reported.

Researchers report a new class of aerial-aquatic robots that can move through both air and water in ways no living animal can, performing transitions and manoeuvres beyond the capabilities of birds, fish or insects. The work, published in Science, highlights how engineering can outperform natural designs in dual-environment robotics, drawing attention across the robotics and science communities.

A new review in Nature examines how synthetic biology is being applied to therapeutics, covering engineered cells, redesigned molecules and biological circuits being developed to treat disease. The field is moving from lab concepts toward clinical use, raising both hopes for new treatments and questions about safety and regulation. Researchers say the approach could reshape how future medicines are designed.

A new commentary argues for 'artificial symbiotic intelligence' — designing AI to work with humans the way symbiosis works in nature, rather than as a replacement. Drawing on biological partnerships, it suggests collaboration, mutual benefit and shared adaptation should guide how AI is built and deployed. The piece adds to an ongoing debate over human-AI teamwork.